AbbVie (ABBV) Raw Materials (2012 - 2016)
AbbVie (ABBV) posted quarterly Raw Materials of $132.0 million for Q2 2016, up 4.76% year-over-year from $126.0 million in Q3 2015, and down 14.84% quarter-over-quarter from $155.0 million in Q1 2016.
AbbVie (ABBV) Raw Materials (2012 - 2016) Analysis & Trends
AbbVie (ABBV) has reported Raw Materials for 5 consecutive years, with $132.0 million the latest figure, recorded in Q2 2016.
- In Q2 2016, Raw Materials rose 4.76% year-over-year to $132.0 million; the TTM figure through Jun 2016 stood at $132.0 million (up 4.76% YoY), while the FY2015 annual figure was $169.0 million, up 9.74% from the prior year.
- Raw Materials declined to $132.0 million in Q2 2016 per ABBV's latest filing, from $155.0 million in the prior quarter.
- Across five years, Raw Materials topped out at $261.0 million in Q4 2013 and bottomed at $126.0 million in Q2 2015.
- Historically, Raw Materials has averaged $188.2 million across 5 years, with a median of $163.0 million in 2015.
- On a YoY basis, Raw Materials climbed as much as 9.74% in 2015 and fell as far as 45.02% in 2015.
- AbbVie's Raw Materials stood at $258.0 million in 2012, then grew by 1.16% to $261.0 million in 2013, then tumbled by 41.0% to $154.0 million in 2014, then climbed by 9.74% to $169.0 million in 2015, then dropped by 21.89% to $132.0 million in 2016.
- Business Quant data shows ABBV's Raw Materials at $132.0 million in Q2 2016, $155.0 million in Q1 2016, and $169.0 million in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 132.00 Mn |
| Mar 31, 2016 | 155.00 Mn |
| Dec 31, 2015 | 169.00 Mn |
| Sep 30, 2015 | 138.00 Mn |
| Jun 30, 2015 | 126.00 Mn |
| Mar 31, 2015 | 163.00 Mn |
| Dec 31, 2014 | 154.00 Mn |
| Sep 30, 2014 | 251.00 Mn |
| Dec 31, 2013 | 261.00 Mn |
| Sep 30, 2013 | 255.00 Mn |
| Jun 30, 2013 | 223.00 Mn |
| Mar 31, 2013 | 162.00 Mn |
| Dec 31, 2012 | 258.00 Mn |